Invesco
TMBR

Invesco’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Invesco’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3
Closed -$5K – 3870
2018
Q4 		$5K Hold
3
– – ﹤0.01% 3794
2018
Q3 		$8K Hold
3
– – ﹤0.01% 3869
2018
Q2 		$11K Buy
+3
New +$10.1K ﹤0.01% 3848

Other funds holding TMBR

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Invesco's TMBR Position: Q1 2019 in Review

Invesco sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2019, closing a stake of 3 shares — an estimated $5K sold.

Invesco first reported a position in TMBR in Q2 2018 and held it in 3 quarters. The position peaked at $11K in Q2 2018. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2019.

  • Invesco reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 3 Timber Pharmaceuticals, Inc. shares in Q1 2019, an estimated $5K.
  • Invesco first reported a position in Timber Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
  • Invesco's Timber Pharmaceuticals, Inc. position peaked at $11K in Q2 2018.
  • 17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.